Topic license agreements

News license agreements

  • Protea Biosciences Concludes New Technology License Agreement

    ProteaBio Europe SAS announced that the company has concluded an exclusive, worldwide license agreement with George Washington University for commercial rights to a new technology that provides rapid identification of a broad range of chemicals and biomolecules. Known as Laser Ablation Electrospray more

  • Max Planck Innovation awards license for actin marker LifeAct

    Max Planck Innovation GmbH, the technology transfer organization of the Max Planck Society, has awarded an exclusive license for LifeAct to ibidi GmbH, a provider of cell analysis products, located in Martinsried near Munich. The novel peptide allows for actin, an important protein, to be made visib more

  • Ehrfeld Mikrotechnik BTS and Lonza cooperate in the microreactor technology

    Ehrfeld Mikrotechnik BTS (EMB), a Bayer Technology Services company, and Lonza signed a worldwide manufacturing and distribution license agreement together with a cooperation and development agreement on the Lonza microreactor technology. Under the terms of the agreements, EMB will acquire a license more

All news on license agreements

Websites license agreements

4-Antibody - Press room

A A Home About Us Investors Management Board of Directors Scientific Advisory Board Technologies Antibodies Overview Intellectual Property Glossary Partnering Press Room Career Contact Maps & Directions Basel Site Maps & Directions Jena Site Press Room Recent news releases March 16, 2010: 4-Antibody more

Compugen - Collaborations - Overview

Overview Therapeutic Collaborations mAb Targets Collaborations Research & Discovery Collaborations Overview Compugen forms collaborations with pharmaceutical, biotechnology and diagnostic companies to develop and commercialize the wide range of discoveries in its portfolio as well as to jointly disc more

Home - AzurPharma

Home Products Pipeline Investors News Careers Management Business Development Company Information Business Development Azur Pharma actively seeks to in-license or acquire FDA approved and late-stage development pharmaceutical products, particularly in the CNS, women’s health or urology areas. Azur P more

All websites on license agreements
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE